Matthew Forrest is a Lead Scientist with over 15 years' hands-on experience developing ISO13485-compliant isothermal point-of-care molecular diagnostics and platforms. He played a key role at TwistDx in commercialising Recombinase Polymerase Amplification (RPA), leading the award-winning TwistAmp Liquid product and contributing to the Alere-i (Abbott ID NOW) CLIA-waived platform. Matthew combines deep assay development and productisation expertise with cross-functional leadership—bridging R&D, manufacturing, QC and commercial teams—to move assays from concept to market. His work spans diverse targets (C. difficile, MRSA, TB, RSV and sexually transmitted infections) and includes practical field-focused design informed by running Wellcome Trust workshops in low-resource settings. Based in Cambridge, he brings 21 years of life-sciences experience and a research pedigree from Berkeley and the Sanger Institute, applying academic rigor to pragmatic diagnostic solutions. Colleagues describe him as a persistent problem-solver who intentionally designs affordable, workable diagnostics for resource-limited environments.
21 years of coding experience
16 years of employment as a software developer
Bachelor of Science (BSc Hons), Genetics, 2:1, Bachelor of Science (BSc Hons), Genetics, 2:1 at University of York
Norwich School
PhD, Molecular Genetics of Prostate Cancer, PhD, Molecular Genetics of Prostate Cancer at Imperial Cancer Research Fund, St James's Hospital, Leeds
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.